Poseida Therapeutics, Inc. (PSTX) Q3 Earnings and Revenues Beat Estimates

Poseida Therapeutics, Inc. (PSTX) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of a loss of $0.42 per share. This compares to loss of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 150%. A quarter ago, it was expected that this company would post a loss of $0.43 per share when it actually produced a loss of $0.32, delivering a surprise of 25.58%.Over the last four quarters, t ...